Publications by authors named "Kjetil Tasken"

Claim this Profile
[
[Not Available].
June Myklebust, Kjetil Taskén

Tidsskr Nor Laegeforen· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accelerating precision oncology by converging pragmatic trials and real-world evidence.
Kjetil Taskén, Piers Mahon

Nat Rev Drug Discov· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer treatment paradigms in the precision medicine era.
Vivek Subbiah, Giuseppe Curigliano, Jason K Sicklick, Shumei Kato, Kjetil Tasken

Nat Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting proteostasis in multiple myeloma through inhibition of LTK.
Thea Kristin Våtsveen, Mariaserena Giliberto, Valgerdur Bjornsdottir, Federica Centonze, Andrej Besse, Kjetil Tasken

Leukemia· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of HLA genotype on disease onset and severity in CTLA-4 insufficiency.
Sara Posadas-Cantera, Noriko Mitsuiki, Florian Emmerich, Virginia Patiño, Hanns-Martin Lorenz

Front Immunol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cyclic nucleotide phosphodiesterases as drug targets.
Michy P Kelly, Viacheslav O Nikolaev, Leila Gobejishvili, Claire Lugnier, Christian Hesslinger, Kjetil Tasken

Pharmacol Rev· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of a group of 9-amino-acridines that selectively downregulate regulatory T cell functions through FoxP3.
Qian Wei, Håvard Foyn, Johannes Landskron, Shixiong Wang, Inga Hansine Rye

iScience· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MAPK and STAT3 Inhibitors Modulate FoxP3 Expression and Regulatory T Cell Function.
Nuria García-Díaz, Elise Solli, Ehsan Hajjar, Selma Cornillot-Clément, Johannes Landskron

Eur J Immunol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-derived acellular ascites fluid affects drug responses in ovarian cancer cell lines through the activation of key signalling pathways.
Katharina Bischof, Andrea Cremaschi, Lena Eroukhmanoff, Johannes Landskron, Lise-Lotte Flage-Larsen

Mol Oncol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acta Oncologica Nordic Precision Cancer Medicine Symposium 2023 - merging clinical research and standard healthcare.
Elisa Bjørgo, Gro L Fagereng, Hege G Russnes, Sigbjørn Smeland, Kjetil Taskén

Acta Oncol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PCM4EU and PRIME-ROSE: Collaboration for implementation of precision cancer medicine in Europe.
Kjetil Taskén, Soemeya F Haj Mohammad, Gro Live Fagereng, Ragnhild Sørum Falk, Åslaug Helland

Acta Oncol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IMPRESS-Norway: improving public cancer care by implementing precision medicine in Norway; inclusion rates and preliminary results.
Katarina Puco, Gro Live Fagereng, Sigmund Brabrand, Pitt Niehusmann, Egil Støre Blix

Acta Oncol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
T cells with increased responsiveness cause obesity in mice without diet intervention.
Ida Gregersen, Xiang Y Kong, Sander Kooijman, Håvard Foyn, Helene Grannes

iScience· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Small molecule inhibitors targeting regulatory T cells for cancer treatment.
Nuria García-Díaz, Qian Wei, Kjetil Taskén

Eur J Immunol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolutionary mode and timing of dissemination of high-grade serous carcinomas.
Anita Sveen, Bjarne Johannessen, Solveig Mk Klokkerud, Sigrid M Kraggerud, Leonardo A Meza-Zepeda

JCI Insight· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Raising the quality of cancer treatment].
Åslaug Helland, Eli Sihn Samdal Steinskog, Egil Støre Blix, Åsmund Flobak, Sigmund Brabrand, Kjetil Tasken

Tidsskr Nor Laegeforen· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diversity of intratumoral regulatory T cells in B-cell non-Hodgkin lymphoma.
Ivana Spasevska, Ankush Sharma, Chloé B Steen, Sarah E Josefsson, Yngvild N Blaker

Blood Adv· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Standardized assays to monitor drug sensitivity in hematologic cancers.
Pilar Ayuda-Durán, Johanne U Hermansen, Mariaserena Giliberto, Yanping Yin, Robert Hanes

Cell Death Discov· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modified study designs to expand treatment options in personalised oncology: a multistakeholder view.
Christophe Le Tourneau, Fabrice André, Åslaug Helland, Linda Mileshkin, Warnyta Minnaard

Eur J Cancer· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disruption of Phosphodiesterase 3A Binding to SERCA2 Increases SERCA2 Activity and Reduces Mortality in Mice With Chronic Heart Failure.
Jonas Skogestad, Ingrid Albert, Karina Hougen, Gustav B Lothe, Marianne Lunde

Circulation· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A tumor microenvironment model of chronic lymphocytic leukemia enables drug sensitivity testing to guide precision medicine.
Johanne U Hermansen, Yanping Yin, Aleksandra Urban, Camilla V Myklebust, Linda Karlsen

Cell Death Discov· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phenotypic deconvolution in heterogeneous cancer cell populations using drug-screening data.
Alvaro Köhn-Luque, Even Moa Myklebust, Dagim Shiferaw Tadele, Mariaserena Giliberto, Leonard Schmiester

Cell Rep Methods· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional precision cancer medicine: drug sensitivity screening enabled by cell culture models.
Åsmund Flobak, Sigrid S Skånland, Eivind Hovig, Kjetil Taskén, Hege G Russnes

Trends Pharmacol Sci· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutational analysis and protein profiling predict drug sensitivity in multiple myeloma cell lines.
Mariaserena Giliberto, Leonardo Miranda Santana, Toril Holien, Kristine Misund, Sigve Nakken

Front Oncol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunoregulatory signal networks and tumor immune evasion mechanisms: insights into therapeutic targets and agents in clinical development.
Qian Wei, Kjetil Taskén

Biochem J· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis